Literature DB >> 24610878

Naturally acquired immunity against human papillomavirus (HPV): why it matters in the HPV vaccine era.

Silvia Franceschi1, Iacopo Baussano1.   

Abstract

Entities:  

Keywords:  HPV; HPV vaccine; antibodies; immunity; mathematical models

Mesh：

Substances：

Year:  2014        PMID： 24610878     DOI： 10.1093/infdis/jiu143

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.

Authors:  Daniel C Beachler; Raphael Viscidi; Elizabeth A Sugar; Howard Minkoff; Howard D Strickler; Ross D Cranston; Dorothy J Wiley; Lisa P Jacobson; Kathleen M Weber; Joseph B Margolick; Susheel Reddy; Maura L Gillison; Gypsyamber D'Souza
Journal:  Sex Transm Dis       Date:  2015-02       Impact factor: 2.830

2.  Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran.

Authors:  Arezoo Aghakhani; Setareh Mamishi; Shahram Sabeti; Farahnaz Bidari-Zerehpoosh; Mohammad Banifazl; Anahita Bavand; Amitis Ramezani
Journal:  Med Microbiol Immunol       Date:  2016-11-17       Impact factor: 3.402

Review 3.  Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis.

Authors:  Daniel C Beachler; Gwendolyne Jenkins; Mahboobeh Safaeian; Aimée R Kreimer; Nicolas Wentzensen
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

4.  Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior.

Authors:  Iacopo Baussano; Fulvio Lazzarato; Marc Brisson; Silvia Franceschi
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

5.  The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.

Authors:  Suzette M Matthijsse; Joost van Rosmalen; Jan A C Hontelez; Roel Bakker; Inge M C M de Kok; Marjolein van Ballegooijen; Sake J de Vlas
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

Review 6.  Natural History of HPV Infection across the Lifespan: Role of Viral Latency.

Authors:  Patti E Gravitt; Rachel L Winer
Journal:  Viruses       Date:  2017-09-21       Impact factor: 5.048

Review 7.  The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.

Authors:  Anna Rosa Garbuglia; Daniele Lapa; Catia Sias; Maria Rosaria Capobianchi; Paola Del Porto
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

8.  Seroprevalence of mucosal and cutaneous human papillomavirus (HPV) types among children and adolescents in the general population in Germany.

Authors:  Anna Loenenbach; Michael Pawlita; Tim Waterboer; Thomas Harder; Christina Poethko-Müller; Michael Thamm; Raskit Lachmann; Yvonne Deleré; Ole Wichmann; Miriam Wiese-Posselt
Journal:  BMC Infect Dis       Date:  2022-01-10       Impact factor: 3.090

9.  Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women.

Authors:  Darron R Brown; Xavier Castellsagué; Daron Ferris; Suzanne M Garland; Warner Huh; Marc Steben; Cosette M Wheeler; Alfred Saah; Alain Luxembourg; Se Li; Christine Velicer
Journal:  Tumour Virus Res       Date:  2022-05-04

Review 10.  New Perspectives in Therapeutic Vaccines for HPV: A Critical Review.

Authors:  Barbara Gardella; Andrea Gritti; Ehsan Soleymaninejadian; Marianna Francesca Pasquali; Gaetano Riemma; Marco La Verde; Maria Teresa Schettino; Nicola Fortunato; Marco Torella; Mattia Dominoni
Journal:  Medicina (Kaunas)       Date:  2022-06-28       Impact factor: 2.948
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.